We provided evidence that modulating NOTCH1 signaling pathway may be of great potential to eliminate CSC populations in HNSCC with a rather tolerable γ-secretase inhibitor48. This evidence concerns the gene NOTCH1 and head and neck squamous cell carcinoma.